Lara Testai1, Vincenzo Barrese2, Maria Virginia Soldovieri3, Paolo Ambrosino3, Alma Martelli1, Iolanda Vinciguerra3, Francesco Miceli4, Iain Andrew Greenwood5, Michael John Curtis6, Maria Cristina Breschi1, Maria Josè Sisalli4, Antonella Scorziello4, Miren Josune Canduela7, Pedro Grandes7, Vincenzo Calderone1, Maurizio Taglialatela8. 1. Department of Pharmacy, University of Pisa, Pisa, Italy. 2. Department of Neuroscience, Division of Pharmacology, University of Naples 'Federico II', Naples, Italy Vascular Biology Research Centre, Institute of Cardiovascular and Cell Sciences, St George's University of London, London, UK. 3. Department of Medicine and Health Science "Vincenzo Tiberio", University of Molise, Campobasso, Italy. 4. Department of Neuroscience, Division of Pharmacology, University of Naples 'Federico II', Naples, Italy. 5. Vascular Biology Research Centre, Institute of Cardiovascular and Cell Sciences, St George's University of London, London, UK. 6. Cardiovascular Division, Faculty of Life Sciences and Medicine, King's College London, London, UK. 7. Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain. 8. Department of Neuroscience, Division of Pharmacology, University of Naples 'Federico II', Naples, Italy Department of Medicine and Health Science "Vincenzo Tiberio", University of Molise, Campobasso, Italy m.taglialatela@unimol.it.
Abstract
AIMS: Plasmalemmal Kv7.1 (KCNQ1) channels are critical players in cardiac excitability; however, little is known on the functional role of additional Kv7 family members (Kv7.2-5) in cardiac cells. In this work, the expression, function, cellular and subcellular localization, and potential cardioprotective role against anoxic-ischaemic cardiac injury of Kv7.4 channels have been investigated. METHODS AND RESULTS: Expression of Kv7.1 and Kv7.4 transcripts was found in rat heart tissue by quantitative polymerase chain reaction. Western blots detected Kv7.4 subunits in mitochondria from Kv7.4-transfected cells, H9c2 cardiomyoblasts, freshly isolated adult cardiomyocytes, and whole hearts. Immunofluorescence experiments revealed that Kv7.4 subunits co-localized with mitochondrial markers in cardiac cells, with ∼ 30-40% of cardiac mitochondria being labelled by Kv7.4 antibodies, a result also confirmed by immunogold electron microscopy experiments. In isolated cardiac (but not liver) mitochondria, retigabine (1-30 µM) and flupirtine (30 µM), two selective Kv7 activators, increased Tl(+) influx, depolarized the membrane potential, and inhibited calcium uptake; all these effects were antagonized by the Kv7 blocker XE991. In intact H9c2 cells, reducing Kv7.4 expression by RNA interference blunted retigabine-induced mitochondrial membrane depolarization; in these cells, retigabine decreased mitochondrial Ca(2+) levels and increased radical oxygen species production, both effects prevented by XE991. Finally, retigabine reduced cellular damage in H9c2 cells exposed to anoxia/re-oxygenation and largely prevented the functional and morphological changes triggered by global ischaemia/reperfusion (I/R) in Langendorff-perfused rat hearts. CONCLUSION: Kv7.4 channels are present and functional in cardiac mitochondria; their activation exerts a significant cardioprotective role, making them potential therapeutic targets against I/R-induced cardiac injury. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Plasmalemmal Kv7.1 (KCNQ1) channels are critical players in cardiac excitability; however, little is known on the functional role of additional Kv7 family members (Kv7.2-5) in cardiac cells. In this work, the expression, function, cellular and subcellular localization, and potential cardioprotective role against anoxic-ischaemic cardiac injury of Kv7.4 channels have been investigated. METHODS AND RESULTS: Expression of Kv7.1 and Kv7.4 transcripts was found in rat heart tissue by quantitative polymerase chain reaction. Western blots detected Kv7.4 subunits in mitochondria from Kv7.4-transfected cells, H9c2 cardiomyoblasts, freshly isolated adult cardiomyocytes, and whole hearts. Immunofluorescence experiments revealed that Kv7.4 subunits co-localized with mitochondrial markers in cardiac cells, with ∼ 30-40% of cardiac mitochondria being labelled by Kv7.4 antibodies, a result also confirmed by immunogold electron microscopy experiments. In isolated cardiac (but not liver) mitochondria, retigabine (1-30 µM) and flupirtine (30 µM), two selective Kv7 activators, increased Tl(+) influx, depolarized the membrane potential, and inhibited calcium uptake; all these effects were antagonized by the Kv7 blocker XE991. In intact H9c2 cells, reducing Kv7.4 expression by RNA interference blunted retigabine-induced mitochondrial membrane depolarization; in these cells, retigabine decreased mitochondrial Ca(2+) levels and increased radical oxygen species production, both effects prevented by XE991. Finally, retigabine reduced cellular damage in H9c2 cells exposed to anoxia/re-oxygenation and largely prevented the functional and morphological changes triggered by global ischaemia/reperfusion (I/R) in Langendorff-perfused rat hearts. CONCLUSION: Kv7.4 channels are present and functional in cardiac mitochondria; their activation exerts a significant cardioprotective role, making them potential therapeutic targets against I/R-induced cardiac injury. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Maria Consiglia Trotta; Monica Salerno; Anna Lisa Brigida; Vincenzo Monda; Antonietta Messina; Carmela Fiore; Roberto Avola; Renato Bernardini; Francesco Sessa; Gabriella Marsala; Guido N Zanghì; Giovanni Messina; Michele D'Amico; Clara Di Filippo Journal: Oncotarget Date: 2017-12-14
Authors: Lara Testai; Irina Strobykina; Victor V Semenov; Marina Semenova; Eleonora Da Pozzo; Alma Martelli; Valentina Citi; Claudia Martini; Maria C Breschi; Vladimir E Kataev; Vincenzo Calderone Journal: Int J Mol Sci Date: 2017-09-26 Impact factor: 5.923
Authors: Jan Hansen; Jacob Johnsen; Jan Møller Nielsen; Charlotte Brandt Sørensen; Casper Carlsen Elkjær; Nichlas Riise Jespersen; Hans Erik Bøtker Journal: Drug Des Devel Ther Date: 2020-07-02 Impact factor: 4.162
Authors: Daniel León-Aparicio; Carolina Salvador; Omar Emiliano Aparicio-Trejo; Alfredo Briones-Herrera; José Pedraza-Chaverri; Luis Vaca; Alicia Sampieri; Teresa Padilla-Flores; Zinaeli López-González; Juan C León-Contreras; Rogelio Hernández-Pando; Laura I Escobar Journal: Int J Mol Sci Date: 2019-10-09 Impact factor: 5.923